Digital PCR Market (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) & Region - Global Forecasts to 2025
Updated on : March 24, 2023
The global digital PCR market in terms of revenue was estimated to be worth $4.9 billion in 2020 and is poised to reach $7.6 billion by 2025, growing at a CAGR of 9.0% from 2020 to 2025.
The shift from plant-derived to genome-based drug discovery is expected to offer significant opportunities for the expansion of the global dPCR and qPCR markets. The field of drug discovery has witnessed a major shift from an empirical approach rooted in plant-derived drug-based therapies to a target-oriented, genome-based therapeutic approach. The advent of genetic target-based drug discovery has resulted in the discovery of DNA and genetic codes, as well as their successful use in pharmacological investigations and pharmaceutical applications. This is a direct consequence of the key technical advances in genomics, such as the development of gene sequencing, efficient synthesis of ligands (through gene amplification techniques such as qPCR and dPCR), and high-throughput screening and evaluation of ligand-target interactions (estimating the end product through qPCR and dPCR analysis).
To know about the assumptions considered for the study, Request for Free Sample Report
Digital PCR Market Dynamics
Drivers: Increasing use of biomarker profiling for disease diagnostics
Biomarkers or genomic markers are characteristic molecules such as nucleic acids (including DNA and micro RNA or mRNA) that can be detected and quantified in body fluids and tissues. A biomarker can be a reliable, specific source for understanding the nature of a disease and drug response by the process of molecular profiling at the epigenetic, genetic, and protein levels. Currently, biomarker analysis is used for diagnostic testing procedures, monitoring the efficacy of treatment, and developing new drugs (especially for cancer or cardiovascular diseases). Biomarker analysis uses qPCR and dPCR technology for detecting and quantifying genetic material from the isolated sample. Over the past decade, biomarker analysis procedures have gained importance in the clinical diagnosis and prognosis of diseases, with an increasing number of public and private organizations focusing on R&D into novel techniques for monitoring disease progression and developing personalized medicines and treatment options.
Restraints: Technical limitations of qPCR and dPCR techniques
A typical qPCR/dPCR method is associated with several technical limitations such as signal measurement during the exponential phase of the PCR reaction, the need for optimization and validation of assay procedures, hindrances in target detection due to the presence of reaction inhibitors, and the failure to detect target molecules due to the low quality of the nucleotide template. In addition, qPCR and dPCR reagents have several procedural limitations that directly affect their adoption in genomic research, such as chemical binding of the reagent to dsDNA (SYBR Green dye), inability to assess DNA quality (AluQuant), and the use of carcinogenic chemicals (Yield gel).
Key Trends: Development of compact, portable, and lab-on-chip PCR devices
Lab-on-chip devices involve the miniaturization and compaction of a procedure into a micro-sized device. This has several technological advantages depending on the field of use. The development of lab-on-chip PCR devices has led to effective temperature modulation during analysis, reduced reagent consumption, and higher sample throughput. Lab-on-chip qPCR is a disruptive technology with the potential to replace the conventional oligonucleotide microarray. These devices offer low fabrication costs, high throughput, faster detector response, and low sample consumption as compared to microarray-based devices. With significant advances in the field of microfluidics and nanotechnology, the development of lab-on-chip PCR devices is gaining pace.
Opportunities: Shift from plant-derived to genome-based drug discovery
Plant-derived drug candidates used for disease management often belong to a chemically similar class of natural products that show almost identical biological activity and often result in a similar set of therapeutic limitations (side-effects, contraindications, dose limits, and site of action). In addition, these natural products may have an unknown site of biological action that leads to unpredictable biological activity and side effects. The therapeutic limitations of plant-derived drugs can be addressed with gene-based drug candidates that have known sites of action (specific genes or proteins).
Challenges: Adoption and implementation of MIQE guidelines
The main challenge for qPCR universal adoption and acceptance includes tedious preparation and considerations needed prior to performing the actual PCR procedure. These considerations pertain to sample storage conditions, reactant quality, and extraction method, among other factors. These factors have restrained the adoption of MIQE guidelines among researchers. Factors such as sample storage conditions, reactant quality, and extraction method have restrained the adoption of MIQE guidelines among researchers.
In 2019, qPCR products & services held the largest share of the market
Based on products & services, the qPCR market is segmented into qPCR products & services and dPCR products & services. In 2019, qPCR products & services segment dominated this market. Quantitative PCR is a well-established PCR technique that is widely utilized in DNA identification, amplification, and quantification. It involves the real-time analysis of reaction mixtures with the aid of fluorescent markers (that are specific to either the end-product or the reactant). The qPCR technique has several benefits over traditional PCR, such as an increased dynamic range of target detection, ability to collect data during the exponential phase of the reaction, no requirement for post-procedure processing, real-time monitoring, time efficiency, and kinetics measurement in the early phases of the reaction.
The hospitals and diagnostic centers held the largest share of the Digital PCR Market, by end user
The hospitals and diagnostic centers segment accounted for the largest share of the dPCR market. This can be attributed to the growing demand for early and efficient disease diagnosis and treatment, increasing number of dPCR product launches for diagnostic applications, benefits offered by dPCR in disease diagnosis (as compared to other PCR technologies), and the growing public awareness related to the benefits offered by dPCR in disease diagnosis.
The infectious disease testing segment of digital PCR market will witness the highest growth in the clinical applications during the forecast period.
Based on application, the market is segmented into clinical applications, research applications, and forensic applications. The infectious disease testing segment will witness the highest growth in the clinical applications during the forecast period. Advanced molecular diagnosis tools such as spectroscopy and liquid chromatography are being integrated with qPCR workflows to offer genomic lab technicians the capability of rapid and accurate pathogen detection. This provides a competitive edge to qPCR over other traditional diagnostic tools such as immunological tests, biochemical tests, and serological examination of samples to detect antibiotic resistance and gene mutation in target microorganisms.
To know about the assumptions considered for the study, download the pdf brochure
North America was the largest region for digital PCR market in 2019.
In 2020, North America is expected to dominate the qPCR and dPCR market, followed by Europe. The US holds a dominant share of the North American dPCR and qPCR market due to factors such as the high incidence of chronic and genetic diseases (coupled with the rising geriatric population), growing adoption of qPCR and dPCR techniques in research and academia, significant public-private funding in the field of genome analysis, and the strong presence of major pharmaceutical and biotechnology companies in the country. The US is a well-developed market for genome analysis techniques that are primarily used in clinical applications by healthcare professionals (such as pathogen detection, disease diagnosis, and DNA identification) and research applications by life science researchers (such as genomics and molecular research).
Prominent players operating in this market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland) are the key players operating in Digital PCR Market. Other prominent players are Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Switzerland), Becton Dikinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), and Quidel Corporation (US).
Digital PCR Market Report Scope
|
Report Metrics |
Details |
|
Market Value in 2020 |
$4.9 billion |
|
Estimated Value by 2025 |
$7.6 billion |
|
Growth Rate |
Poised to grow at a CAGR of 9.0% |
|
Market Segmentation |
qPCR Products & Services, Application, End User And Regional Level |
|
Market Driver |
Increasing use of biomarker profiling for disease diagnostics |
|
Market Opportunity |
Shift from plant-derived to genome-based drug discovery |
|
Geographies Covered |
North America, Europe, APAC, MEA, and Latin America |
This report categorizes the Digital PCR Market into the following segments and sub-segments:
By Product & Service
-
qPCR Products & Services
- qPCR Reagents and Consumables
- qPCR Instruments
- qPCR Software and Services
-
dPCR Products & Services
- dPCR Instruments
- dPCR Reagents and Consumables
- dPCR Software and Services
By Application
-
qPCR Applications
- Clinical Applications
- Research Applications
- Forensic Applications
-
dPCR Applications
- Clinical Applications
- Research Applications
- Forensic Applications
By End User
-
qPCR End User
- Hospitals and Diagnostic Centers
- Research Laboratories and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
- Forensic Laboratories
-
qPCR End User
- Hospitals and Diagnostic Centers
- Research Laboratories and Academic Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Research Organizations
- Forensic Laboratories
Recent Developments:
- In 2020, Thermo Fisher Scientific, Inc received US FDA emergency use authorization (EUA) for SARS-CoV-2 multiplex real-time PCR test.
- In 2020, Roche Diagnostics received US FDA 510k clearance for cobas BKV test.
- In 2020, Abbott Laboratories received US FDA EUA ALINITY m SARS-CoV-2 ASSAY
- In 2019, Bio-Rad Laboratories, Inc. Received the US FDA’s approval for its QXDx AutoDG ddPCR System and the QXDx BCR-ABL %IS Kit.
Frequently Asked Questions (FAQs):
What is the projected market value of the global Digital PCR Market?
The global market of Digital PCR Market is projected to reach USD 7.6 Billion.
What is the estimated growth rate (CAGR) of the global Digital PCR Market for the next five years?
The global Digital PCR Market is projected to grow at a Compound Annual Growth Rate (CAGR) of 9.0% from 2020 to 2025.
What are the major revenue pockets in the Digital PCR Market currently?
In 2020, North America is expected to dominate the qPCR and dPCR market, followed by Europe. The US holds a dominant share of the North American dPCR and qPCR market due to factors such as the high incidence of chronic and genetic diseases (coupled with the rising geriatric population), growing adoption of qPCR and dPCR techniques in research and academia, significant public-private funding in the field of genome analysis, and the strong presence of major pharmaceutical and biotechnology companies in the country.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 35)
1.1 OBJECTIVES OF THE STUDY
1.2 GLOBAL dPCR MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
FIGURE 1 THE MARKET FOR DPCR AND QPCR IS EXPECTED TO WITNESS ROBUST GROWTH DURING THE FORECAST PERIOD, COMPARED WITH THE PREVIOUS ESTIMATES OF THIS MARKET
2 RESEARCH METHODOLOGY (Page No. - 40)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primaries
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL DIGITAL PCR MARKET
2.2.3 GROWTH FORECAST
2.2.4 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY)
2.2.5 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RISK ANALYSIS
3 EXECUTIVE SUMMARY (Page No. - 50)
FIGURE 6 GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 7 GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 GLOBAL QPCR MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 GLOBAL dPCR MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 DIGITAL PCR MARKET: GEOGRAPHIC SNAPSHOT
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 GLOBAL DPCR AND REAL TIME PCR MARKET OVERVIEW
FIGURE 11 RISING INCIDENCE OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH
4.2 NORTH AMERICAN dPCR MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE DIGITAL PCR MARKET DURING THE FORECAST PERIOD
4.3 GEOGRAPHICAL SNAPSHOT OF THE DPCR AND QPCR MARKET
FIGURE 13 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 GLOBAL dPCR MARKET DYNAMICS
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 KEY MARKET DRIVERS
5.2.1.1 Rising incidence of target infectious diseases and genetic disorders
FIGURE 15 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2019
FIGURE 16 GROWING GERIATRIC POPULATION ACROSS KEY REGIONS (2017 VS. 2030)
5.2.1.2 Technological advancements in PCR technologies
FIGURE 17 TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY
5.2.1.3 Increasing investments, funds, and grants
5.2.1.4 Increasing use of biomarker profiling for disease diagnostics
5.2.1.5 Successful completion of the Human Genome Project
5.2.2 KEY MARKET RESTRAINTS
5.2.2.1 High device costs associated with dPCR
5.2.2.2 Technical limitations of qPCR and dPCR techniques
5.2.3 KEY MARKET OPPORTUNITIES
5.2.3.1 Growing market penetration in emerging countries
5.2.3.2 Shift from plant-derived to genome-based drug discovery
5.2.4 KEY MARKET CHALLENGES
5.2.4.1 Adoption and implementation of MIQE guidelines
5.2.5 KEY MARKET TRENDS
5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices
5.2.5.2 Ongoing technological integration with the PCR process
5.3 COVID-19 IMPACT ON THE DIGITAL PCR (DPCR) AND REAL-TIME PCR (QPCR) MARKET
6 DPCR MARKET, BY PRODUCT & SERVICE (Page No. - 69)
6.1 INTRODUCTION
TABLE 1 DIGITAL PCR MARKET, BY TECHNOLOGY, 2016–2019 (USD MILLION)
TABLE 2 DPCR AND REAL TIME PCR MARKET, BY TECHNOLOGY, 2020–2025 (USD MILLION)
6.2 QPCR PRODUCTS & SERVICES
TABLE 3 QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 4 QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 5 QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 6 QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.1 QPCR REAGENTS AND CONSUMABLES
TABLE 7 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 8 QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.1.1 qPCR reagents and consumables market, by application
TABLE 9 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 10 QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
6.2.1.2 qPCR reagents and consumables market, by end user
TABLE 11 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 12 QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2020–2025 (USD MILLION)
6.2.2 QPCR INSTRUMENTS
TABLE 13 QPCR INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 14 QPCR INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.2.1 qPCR instruments market, by application
TABLE 15 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 16 QPCR INSTRUMENTS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
6.2.2.2 qPCR instruments market, by end user
TABLE 17 QPCR INSTRUMENTS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 18 QPCR INSTRUMENTS MARKET, BY END USER, 2020–2025 (USD MILLION)
6.2.3 QPCR SOFTWARE AND SERVICES
TABLE 19 QPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 20 QPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.2.3.1 qPCR software and services market, by application
TABLE 21 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 22 QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
6.2.3.2 qPCR software and services market, by end user
TABLE 23 QPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 24 QPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
6.3 DPCR PRODUCTS & SERVICES
TABLE 25 DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 26 DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 27 DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 28 DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.1 DPCR INSTRUMENTS
TABLE 29 DPCR INSTRUMENTS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 30 DPCR INSTRUMENTS MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.1.1 dPCR instruments market, by application
TABLE 31 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
6.3.1.2 dPCR instruments market, by application
TABLE 32 DPCR INSTRUMENTS MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
6.3.1.3 dPCR instruments market, by end user
TABLE 33 DPCR INSTRUMENTS MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 34 DPCR INSTRUMENTS MARKET, BY END USER, 2020–2025 (USD MILLION)
6.3.2 DPCR REAGENTS AND CONSUMABLES
TABLE 35 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 36 DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.2.1 dPCR reagents and consumables market, by application
TABLE 37 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 38 DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
6.3.2.2 dPCR reagents and consumables market, by end user
TABLE 39 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 40 DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER, 2020–2025 (USD MILLION)
6.3.3 DPCR SOFTWARE AND SERVICES
TABLE 41 DPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 42 DPCR SOFTWARE AND SERVICES MARKET, BY REGION, 2020–2025 (USD MILLION)
6.3.3.1 dPCR software and services market, by application
TABLE 43 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
6.3.3.2 dPCR software and services market, by application
TABLE 44 DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
6.3.3.3 dPCR software and services market, by end user
TABLE 45 DPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 46 DPCR SOFTWARE AND SERVICES MARKET, BY END USER, 2020–2025 (USD MILLION)
7 DPCR MARKET, BY APPLICATION (Page No. - 97)
7.1 INTRODUCTION
7.2 QPCR APPLICATIONS
TABLE 47 GLOBAL QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 48 GLOBAL REAL TIME PCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
7.2.1 CLINICAL APPLICATIONS
TABLE 49 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 50 GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 51 QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 52 QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.2.1.1 Infectious disease testing
7.2.1.1.1 The wide availability of qPCR assays and kits for infectious disease testing is a key factor driving market growth
TABLE 53 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 54 QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020–2025 (USD MILLION)
7.2.1.2 Oncology testing
7.2.1.2.1 The advent of alternative diagnostic technologies for oncology testing is a key factor restraining market growth
TABLE 55 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 56 QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2020–2025 (USD MILLION)
7.2.1.3 Blood screening
7.2.1.3.1 The elimination of post-amplification processing and easy process automation to drive the demand for qPCR products
TABLE 57 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2016–2019 (USD MILLION)
TABLE 58 QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2020–2025 (USD MILLION)
7.2.1.4 Transplant diagnostics
7.2.1.4.1 Increasing commercialization of qPCR products for transplant diagnostics to drive the market growth
TABLE 59 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2016–2019 (USD MILLION)
TABLE 60 QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2020–2025 (USD MILLION)
7.2.1.5 Other clinical applications
TABLE 61 QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 62 REAL TIME PCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
7.2.2 RESEARCH APPLICATIONS
7.2.2.1 Increase in genome-based research activity boosts the market growth
TABLE 63 QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 64 QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2020 –2025 (USD MILLION)
7.2.3 FORENSIC APPLICATIONS
7.2.3.1 Limited adoption of qPCR in underdeveloped and developing countries is expected to restrict the market growth
TABLE 65 QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 66 QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.3 DPCR APPLICATIONS
TABLE 67 GLOBAL DIGITAL PCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 68 GLOBAL dPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
7.3.1 CLINICAL APPLICATIONS
TABLE 69 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2016–2019 (USD MILLION)
TABLE 70 GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE, 2020–2025 (USD MILLION)
TABLE 71 DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 72 DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.3.1.1 Infectious disease testing
7.3.1.1.1 Accuracy and precision of dPCR have made it a prominent tool in infectious disease testing
TABLE 73 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 74 DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION, 2020–2025 (USD MILLION)
7.3.1.2 Oncology testing
7.3.1.2.1 dPCR plays a vital role in oncology testing and clinical studies
TABLE 75 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2016–2019 (USD MILLION)
TABLE 76 DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2020–2025 (USD MILLION)
7.3.1.3 Blood screening
7.3.1.3.1 dPCR offers multiple advantages over traditional techniques for blood screening
TABLE 77 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2016–2019 (USD MILLION)
TABLE 78 DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2020–2025 (USD MILLION)
7.3.1.4 Transplant diagnostics
7.3.1.4.1 Low market availability of dPCR products for transplant diagnostics to reflect in the small share of this segment
TABLE 79 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2016–2019 (USD MILLION)
TABLE 80 DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2020–2025 (USD MILLION)
7.3.1.5 Other clinical applications
TABLE 81 DIGITAL PCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 82 dPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2020–2025 (USD MILLION)
7.3.2 RESEARCH APPLICATIONS
7.3.2.1 Wide usage of dPCR in genetic research is the primary driver for market growth
TABLE 83 DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 84 DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
7.3.3 FORENSIC APPLICATIONS
7.3.3.1 The need to reduce the time & cost of forensic processes is a key factor driving market growth
TABLE 85 DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 86 DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2020–2025 (USD MILLION)
8 DPCR MARKET, BY END USER (Page No. - 125)
8.1 INTRODUCTION
8.2 QPCR END USERS
TABLE 87 QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 88 REAL TIME PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
8.2.1 HOSPITALS AND DIAGNOSTIC CENTERS
TABLE 89 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 90 QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2025 (USD MILLION)
8.2.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
TABLE 91 QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
TABLE 92 REAL TIME PCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2020–2025 (USD MILLION)
8.2.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
TABLE 93 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 94 QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2025 (USD MILLION)
8.2.4 CLINICAL RESEARCH ORGANIZATIONS
TABLE 95 REAL TIME PCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 96 QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2020–2025 (USD MILLION)
8.2.5 FORENSIC LABORATORIES
TABLE 97 QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 98 I REAL TIME PCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2020–2025 (USD MILLION)
8.3 DPCR END USERS
TABLE 99 DIGITAL PCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 100 DPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
8.3.1 HOSPITALS AND DIAGNOSTIC CENTERS
TABLE 101 dPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2016–2019 (USD MILLION)
TABLE 102 DIGITAL PCR MARKETFOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2020–2025 (USD MILLION)
8.3.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
TABLE 103 dPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2016–2019 (USD MILLION)
TABLE 104 DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2020–2025 (USD MILLION)
8.3.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
TABLE 105 DIGITAL PCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 106 dPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2025 (USD MILLION)
8.3.4 CLINICAL RESEARCH ORGANIZATIONS
TABLE 107 DIGITAL PCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016–2019 (USD MILLION)
TABLE 108 DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2020–2025 (USD MILLION)
8.3.5 FORENSIC LABORATORIES
TABLE 109 dPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2016–2019 (USD MILLION)
TABLE 110 DIGITAL PCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2020–2025 (USD MILLION)
9 DPCR MARKET, BY REGION (Page No. - 144)
9.1 INTRODUCTION
TABLE 111 DIGITAL PCR MARKET, BY REGION, 2016–2019 (USD MILLION)
TABLE 112 DPCR AND QPCR MARKET, BY REGION, 2020–2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 18 NORTH AMERICA: DIGITAL PCR MARKET SNAPSHOT
TABLE 113 NORTH AMERICA: dPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 114 NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 115 NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 116 NORTH AMERICA: dPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 117 NORTH AMERICA: dPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 118 NORTH AMERICA: REAL TIME PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 119 NORTH AMERICA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 120 NORTH AMERICA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 121 NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 122 NORTH AMERICA: dPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 123 NORTH AMERICA: DIGITAL PCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 124 NORTH AMERICA: dPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 125 NORTH AMERICA: REAL TIME PCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 126 NORTH AMERICA: dPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
TABLE 127 NORTH AMERICA: DPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 128 NORTH AMERICA: DIGITAL PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominated the North American dPCR and qPCR market in 2019
TABLE 129 US: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 130 US: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 131 US: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 132 US: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada
TABLE 133 CANADA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 134 CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 135 CANADA: dPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 136 CANADA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.3 EUROPE
TABLE 137 EUROPE: DIGITAL PCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 138 EUROPE: dPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 139 EUROPE: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 140 EUROPE: DIGITAL PCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 141 EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 142 EUROPE: REAL TIME PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 143 EUROPE: dPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 144 EUROPE: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 145 EUROPE: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 146 EUROPE: dPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 147 EUROPE: DPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 148 EUROPE: DIGITAL PCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 149 EUROPE: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 150 EUROPE: REAL TIME PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
TABLE 151 EUROPE: dPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 152 EUROPE: DIGITAL PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominates the European dPCR and qPCR market
TABLE 153 GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 154 GERMANY: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 155 GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 156 GERMANY: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.3.2 UK
9.3.2.1 Growing focus on genomics research to support market growth in the UK
TABLE 157 UK: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 158 UK: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 159 UK: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 160 UK: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Initiatives for developing genomic medicine to support market growth in France
TABLE 161 FRANCE: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 162 FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 163 FRANCE: dPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 164 FRANCE: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.3.4 REST OF EUROPE
TABLE 165 ROE: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 166 ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 167 ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 168 ROE: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 19 ASIA PACIFIC: DPCR AND QPCR MARKET SNAPSHOT
TABLE 169 APAC: dPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 170 APAC: QPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 171 APAC: DPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 172 APAC: DIGITAL PCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 173 ASIA PACIFIC: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 174 ASIA PACIFIC: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 175 ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 176 ASIA PACIFIC: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 177 ASIA PACIFIC: dPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 178 ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 179 ASIA PACIFIC: dPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 180 ASIA PACIFIC: DIGITAL PCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 181 ASIA PACIFIC: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 182 ASIA PACIFIC: REAL TIME PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
TABLE 183 ASIA PACIFIC: dPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 184 ASIA PACIFIC: DIGITAL PCR MARKET, BY END USER, 2020–2025(USD MILLION)
9.4.1 JAPAN
9.4.1.1 Strong research and healthcare infrastructure to support market growth in Japan
TABLE 185 JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 186 JAPAN: REAL TIME PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 187 JAPAN: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 188 JAPAN: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Healthcare infrastructure modernization to support market growth in China
TABLE 189 CHINA: dPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 190 CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 191 CHINA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 192 CHINA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Presence of a large target patient population to support market growth in India
TABLE 193 INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 194 INDIA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 195 INDIA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 196 INDIA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.4.4 REST OF APAC
TABLE 197 ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 198 ROAPAC: REAL TIME PCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 199 ROAPAC: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 200 ROAPAC: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.5 LATIN AMERICA
TABLE 201 LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 202 LATIN AMERICA: REAL TIME PCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 203 LATIN AMERICA: DIGITAL PCR MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
TABLE 204 LATIN AMERICA: dPCR MARKET, BY COUNTRY, 2020–2025 (USD MILLION)
TABLE 205 LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 206 LATIN AMERICA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 207 LATIN AMERICA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 208 LATIN AMERICA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 209 LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 210 LATIN AMERICA: REAL TIME PCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 211 LATIN AMERICA: DIGITAL PCR MARKET, BY APPLICATION, 2016 -2019 (USD MILLION)
TABLE 212 LATIN AMERICA: dPCR MARKET, BY APPLICATION, 2020 -2025 (USD MILLION)
TABLE 213 LATIN AMERICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 214 LATIN AMERICA: dPCR MARKET, BY END USER, 2020–2025(USD MILLION)
TABLE 215 LATIN AMERICA: DIGITAL PCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 216 LATIN AMERICA: DIGITAL PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Brazil dominates the LATAM market
TABLE 217 BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 218 BRAZIL: REAL TIME PCR MARKET, BY PRODUCT & SERVICE, 2020--2025 (USD MILLION)
TABLE 219 BRAZIL: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 220 BRAZIL: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 Favorable trade agreements will support imports and improve access to dPCR and qPCR instruments in Mexico
TABLE 221 MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 222 MEXICO: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 223 MEXICO: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 224 MEXICO: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 225 ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 226 ROLATAM: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 227 ROLATAM: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 228 ROLATAM: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA
TABLE 229 MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 230 MIDDLE EAST AND AFRICA: dPCR MARKET, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION)
TABLE 231 MIDDLE EAST AND AFRICA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2016–2019 (USD MILLION)
TABLE 232 MIDDLE EAST AND AFRICA: DIGITAL PCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 234 MIDDLE EAST AND AFRICA: dPCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 235 MIDDLE EAST AND AFRICA: dPCR MARKET, BY APPLICATION, 2016–2019 (USD MILLION)
TABLE 236 MIDDLE EAST AND AFRICA: DIGITAL PCR MARKET, BY APPLICATION, 2020–2025 (USD MILLION)
TABLE 237 MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER, 2016–2019 (USD MILLION)
TABLE 238 MIDDLE EAST AND AFRICA: REAL TIME PCR MARKET, BY END USER, 2020–2025 (USD MILLION)
TABLE 239 MIDDLE EAST AND AFRICA: DIGITAL PCR MARKET, BY END USER, 2016–2020 (USD MILLION)
TABLE 240 MIDDLE EAST AND AFRICA: dPCR MARKET, BY END USER, 2020–2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 209)
10.1 OVERVIEW
FIGURE 20 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DPCR AND QPCR MARKET, 2016–2020
10.2 MARKET SHARE ANALYSIS
10.2.1 QPCR MARKET SHARE ANALYSIS (2019)
FIGURE 21 REAL TIME PCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
10.2.2 DIGITAL PCR MARKET SHARE ANALYSIS (2019)
FIGURE 22 dPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)
10.3 COMPETITIVE SCENARIO
10.3.1 KEY PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (2016–2020)
10.3.2 KEY PARTNERSHIPS AND COLLABORATIONS (2016–2020)
10.3.3 KEY ACQUISITIONS (2016–2020)
10.3.4 KEY EXPANSIONS (2016–2020)
10.4 DIGITAL PCR AND REAL-TIME (QPCR) MARKET: COMPANY EVALUATION QUADRANT, 2019
10.4.1 COMPANY EVALUATION QUADRANT: MAJOR MARKET PLAYERS (2018)
10.4.1.1 Stars
10.4.1.2 Emerging Leaders
10.4.1.3 Pervasive
10.4.1.4 Emerging Companies
FIGURE 23 GLOBAL COMPANY EVALUATION QUADRANT (OVERALL MARKET)
10.4.2 OMPANY EVALUATION QUADRANT: EMERGING COMPANIES/SMES/START-UPS (2018)
10.4.2.1 Progressive Companies
10.4.2.2 Starting Blocks
10.4.2.3 Responsive Companies
10.4.2.4 Dynamic Companies
FIGURE 24 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
11 COMPANY PROFILES (Page No. - 219)
(Business overview, Products and Services offered, Recent developments & MnM View)*
11.1 THERMO FISHER SCIENTIFIC
FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)
11.2 BIO-RAD LABORATORIES
FIGURE 26 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019)
11.3 ROCHE DIAGNOSTICS
FIGURE 27 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019)
11.4 ABBOTT LABORATORIES
FIGURE 28 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.5 AGILENT TECHNOLOGIES
FIGURE 29 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019)
11.6 ANALYTIK JENA AG
FIGURE 30 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2019)
11.7 BECTON DICKINSON AND COMPANY
FIGURE 31 BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
11.8 BIOMÉRIEUX S.A.
FIGURE 32 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2019)
11.9 DANAHER CORPORATION
FIGURE 33 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
11.10 EPPENDORF AG
FIGURE 34 EPPENDORF AG: COMPANY SNAPSHOT (2019)
11.11 FLUIDIGM CORPORATION
FIGURE 35 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019)
11.12 MERCK KGAA
FIGURE 36 MERCK KGAA: COMPANY SNAPSHOT (2019)
11.13 QIAGEN N.V.
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2019)
11.14 TAKARA BIO
FIGURE 38 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019)
11.15 MERIDIAN BIOSCIENCE
FIGURE 39 MERIDIAN BIOSCIENCE: COMPANY SNAPSHOT (2019)
11.16 QUIDEL CORPORATION
FIGURE 40 QUIDEL CORPORATION: COMPANY SNAPSHOT (2019)
11.17 PROMEGA CORPORATION
11.18 ENZO LIFE SCIENCES
11.19 BIONEER CORPORATION
11.20 ELITECH GROUP
11.21 QUANTA BIOSCIENCES
11.22 SACACE BIOTECHNOLOGIES S.R.L.
11.23 BIO MOLECULAR SYSTEMS
11.24 BIOMEME
11.25 JN MEDSYS PTE. LTD.
11.26 STILLA TECHNOLOGIES
11.27 KYRATEC
11.28 LGC BIOSEARCH TECHNOLOGIES
FIGURE 41 LGC SCIENCE GROUP HOLDINGS LIMITED: COMPANY SNAPSHOT (2019)
11.29 COLE-PARMER INSTRUMENT COMPANY
11.30 GENOME DIAGNOSTICS PVT. LTD.
*Details on Business overview, Products and Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12 ADJACENT RELATED MARKET (Page No. - 300)
12.1 INTRODUCTION
12.2 LIMITATIONS
12.3 MOLECULAR DIAGNOSTIC MARKET
12.3.1 MARKET DEFINATION
12.3.2 MARKET OVERVIEW
12.3.3 MOLECULAR DIAGNOSTICS MARKET, BY REGION
TABLE 241 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.3.3.1 North America
TABLE 242 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
12.3.3.2 Europe
TABLE 243 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
12.3.3.3 Asia pacific
TABLE 244 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
12.3.3.4 Rest of the World
TABLE 245 ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
12.4 IN VITRO DIAGNOSTIC (IVD) MARKET
12.4.1 MARKET DEFINATION
12.4.2 MARKET OVERVIEW
12.4.3 IN VITRO DIAGNOSTIC MARKET, BY REGION
TABLE 246 IVD MARKET, BY REGION, 2018–2025 (USD MILLION)
12.4.3.1 North America
TABLE 247 NORTH AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
12.4.3.2 Europe
TABLE 248 EUROPE: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
12.4.3.3 Asia Pacific
TABLE 249 ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
12.5 LIFE SCIENCE INSTRUMENTATION MARKET
12.5.1 MARKET DEFINITION
12.5.2 MARKET OVERVIEW
12.5.3 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION
TABLE 250 LIFE SCIENCE INSTRUMENTATION MARKET, BY REGION, 2017–2025 (USD MILLION)
12.5.3.1 North America
TABLE 251 NORTH AMERICA LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
12.5.3.2 Europe
TABLE 252 EUROPE LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
12.5.3.3 Asia Pacific
TABLE 253 ASIA PACIFIC LIFE SCIENCE INSTRUMENTATION MARKET, BY COUNTRY, 2017–2025 (USD MILLION)
13 APPENDIX (Page No. - 309)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global dPCR and qPCR market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the dPCR and qPCR market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Secondary Data
This research study involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, companies’ house documents, investor presentations, and SEC filings of companies. The secondary sources referred to for (this research study include publications from government sources, such as World Health Organization (WHO), National Institutes of Health (NIH), Organisation for Economic Co-operation and Development (OECD), Global Cancer Observatory (GLOBOCAN), World Bank, Joint United Nations Programme on HIV and AIDS (UNAIDS), International Trade Administration, National Human Genome Research Institute (NHGRI),, Institute for Health Metrics and Evaluation (US), US FDA, Health Canada, European Medicines Agency (UK), German Cancer Research Center, NHS (UK), Medicines and Healthcare Products Regulatory Agency (UK), UK Biobank, French National Research Agency (France), Italian National Institute of Health, Pharmaceuticals and Medical Devices Agency (Japan), National Cancer Center (Japan), Beijing Institute of Genomics (China), Chinese Academy of Sciences, Ministry of Science & Technology (India), Ministry of Health and Family Welfare (India), Brazilian Health Regulatory Agency (Brazil), African Cancer Registry Network (UK) among others.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the dPCR and qPCR market. It was also used to obtain important information about the key players and market classification, segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Data
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.
Primary sources from demand side includes personnel from pharmaceutical and biotechnology companies and academic and research institutes, and purchase managers in healthcare provider organizations and supply-side includes C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others.
Primary research was used in this report to:
- Validate the market segmentation defined through product portfolio assessment of leading players in the dPCR and qPCR market
- Understand key industry trends and issues defining the strategic growth objectives of market players
- Gather both demand- and supply-side validation of key factors affecting the market growth (such as market drivers, challenges, and opportunities)
- Validate assumptions for the market sizing and forecasting model used for this study
- Understand the market position of leading players in the dPCR and qPCR market and their market share/ranking
To know about the assumptions considered for the study, download the pdf brochure
Data Triangulation
After arriving at the overall market size, from the market size estimation process explained above, the dPCR and qPCR market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the dPCR and qPCR market
Report Objectives
- To define, describe, segment, and forecast the dPCR and qPCR market on the basis of product & services, application, end user, and region
- To provide detailed information about the factors influencing market growth, such as drivers, restraints, opportunities, and challenges
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall dPCR and qPCR market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments concerning five main regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), and the Middle East & Africa (MEA)
- To strategically profile the key players in the global dPCR and qPCR market and comprehensively analyze their core competencies2 and market rankings
- To track and analyze competitive developments, such as product launches & approvals, acquisitions, collaborations, agreements, expansions, and partnerships in the dPCR and qPCR market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the European dPCR and qPCR market into countries from the Rest of Europe segment.
- Further breakdown of the Asia Pacific dPCR and qPCR market into countries from the Rest of the APAC segment.
- Further breakdown of Rest of Latin America and the Middle East & Africa dPCR and qPCR market into countries.
Company Information
Detailed analysis and profiling of additional market players (up to 5) inclusive of:
- Business Overview
- Financial Information
- Product Offered
- Developments (Last three years)
Growth opportunities and latent adjacency in Digital PCR Market
Want more details on Digital PCR Market Statistics, Size, Share, Growth and Report, Segment Analysis, Forecast upto 2030
What is the expected growth rate of the Digital PCR Market in the North American region?
As per this report, what are some of the significant growth opportunities available in the global Digital PCR Market? How will the market change in the future?